AMG 595, an Anti-EGFRvIII Antibody–Drug Conjugate, Induces Potent Antitumor Activity against EGFRvIII-Expressing GlioblastomaKevin J. Hamblett, William C. Fanslow, Sophia Siu et al.|Molecular Cancer Therapeutics|2015Cited by 99
LGR5 promotes the proliferation and tumor formation of cervical cancer cells through the Wnt/β-catenin signaling pathwayQing Chen, Peng‐Sheng Zheng|Oncotarget|2014Cited by 75